Bruker Introduces Enhanced 3D Holographic Stimulation for Optogenetics on its Ultima 2Pplus Multiphoton MicroscopeBusiness Wire • 06/14/22
Bruker Announces Key Innovations for Highly Multiplexed Spatial Proteomics and Multiomic Tissue Imaging at Large Field-of-ViewBusiness Wire • 06/06/22
Bruker Introduces Novel Point-of-Need Applied Mass Spectrometry Tools for Accelerated Measurements without ChromatographyBusiness Wire • 06/06/22
Bruker Launches timsTOF HT with Greater Dynamic Range for Further Enhancing Unbiased, High-Confidence 4D Proteomics™Business Wire • 06/06/22
Bruker and TOFWERK Form Strategic Partnership in High-Speed, Ultra-Sensitive Solutions for Applied and Industrial MarketsBusiness Wire • 05/10/22
Bruker Corporation (BRKR) CEO Frank Laukien on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/04/22
Bruker Announces Date and Time of First Quarter 2022 Earnings Release and WebcastBusiness Wire • 04/18/22
Bruker Announces Key Innovations for Multiplexed Spatial Proteomics and Unbiased Multiomic Imaging for Cancer ResearchBusiness Wire • 04/11/22
IonSense, a Leader In DART™ Mass Spectroscopy, Announces Acquisition by Bruker to Accelerate DART-MS Methods and Applications DevelopmentBusiness Wire • 04/06/22
Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and TechnologiesBusiness Wire • 04/05/22